drugset

drugset / Trial / NCT00521170

Wheal and Flare Reaction During 24 Hours in Allergic Volunteers.

NCT00521170 ↗

Phase 1 Completed UCB Pharma

RandomizedCrossoverDouble-blindTreatment

Summary

Compare the activity of 5 mg levocetirizine and 5 mg desloratadine on allergen-induced wheal and flare reaction.

Timeline

Start: 2004-11
Primary completion: 2005-01
Completion: 2005-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Levocetirizine	Unknown	5 mg	Oral

Indications